Please wait while the transcript is being prepared...
0:00
Ladies and gentlemen, my
name is Ulrich Hagemann.
Welcome to this talk about
the multidimensional landscape
of pharmacovigilance.
0:13
I got my university
education in Pharmacy
and Biochemistry at the
Free University of Berlin.
Thereafter I started to work for
the German medicines
National Drug Agency,
the Federal Institute
of drugs and
medical devices, first in
Berlin and later in Bonn.
Since 1996, I was leading
the pharmacovigilance
department at
this institute until
my retirement in 2011.
Currently, I'm retired and
a member of the Editorial Board,
of the International Journal of
Risk and Safety in Medicine.
0:55
These are my conflicts
of interests.
I have no conflicts of
interests to be declared.
The views expressed in this
presentation reflect my
personal views of the issue.
1:09
I have decided to
divide my talk into
two parts because there are
different issues which
relate to pharmacovigilance,
but which are not really
straightforward connected.
In this first part,
I would like to talk about
the history and disasters
in pharmacovigilance,
I would like to address
the science and
knowledge which are
needed in pharmacovigilance
and the areas of research.
I would like to outline what is
the link between
pharmacovigilance and
public health and what is
the needed clinical
medicine expertise
in pharmacovigilance.